These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 12490810)

  • 1. New innovative therapies for benign prostatic hyperplasia: any advance?
    Klingler HC
    Curr Opin Urol; 2003 Jan; 13(1):11-5. PubMed ID: 12490810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microwave thermotherapy for benign prostatic hyperplasia.
    Hoffman RM; Monga M; Elliot SP; Macdonald R; Wilt TJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD004135. PubMed ID: 17943811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermotherapy and thermoablation for benign prostatic hyperplasia.
    Gravas S; Laguna P; de la Rosette J
    Curr Opin Urol; 2003 Jan; 13(1):45-9. PubMed ID: 12490815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are stents still a useful therapy for benign prostatic hyperplasia?
    Ogiste JS; Cooper K; Kaplan SA
    Curr Opin Urol; 2003 Jan; 13(1):51-7. PubMed ID: 12490816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of benign prostatic hyperplasia.
    Pinheiro LC; Martins Pisco J
    Tech Vasc Interv Radiol; 2012 Dec; 15(4):256-60. PubMed ID: 23244720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
    Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
    Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological and biological predictors for treatment outcome of transurethral microwave thermotherapy.
    Seitz C; Djavan B; Marberger M
    Curr Opin Urol; 2002 Jan; 12(1):25-32. PubMed ID: 11753130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update of the minimally invasive therapies for benign prostatic hyperplasia.
    Naspro R; Salonia A; Colombo R; Cestari A; Guazzoni G; Rigatti P; Montorsi F
    Curr Opin Urol; 2005 Jan; 15(1):49-53. PubMed ID: 15586031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.
    Rosario DJ; Phillips JT; Chapple CR
    J Urol; 2007 Mar; 177(3):1047-51; discussion 1051. PubMed ID: 17296409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign prostatic hyperplasia.
    Barry M; Roehrborn C
    Clin Evid; 2002 Jun; (7):775-87. PubMed ID: 12230703
    [No Abstract]   [Full Text] [Related]  

  • 11. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction.
    Oelke M; Bachmann A; Descazeaud A; Emberton M; Gravas S; Michel MC; N'dow J; Nordling J; de la Rosette JJ;
    Eur Urol; 2013 Jul; 64(1):118-40. PubMed ID: 23541338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign prostatic hyperplasia. Practical treatment guidelines.
    Tammela T
    Drugs Aging; 1997 May; 10(5):349-66. PubMed ID: 9143856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update.
    Cornu JN; Ahyai S; Bachmann A; de la Rosette J; Gilling P; Gratzke C; McVary K; Novara G; Woo H; Madersbacher S
    Eur Urol; 2015 Jun; 67(6):1066-1096. PubMed ID: 24972732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and assessment of minimally invasive approaches to benign prostatic hyperplasia therapy.
    Larson TR
    Urology; 2002 Feb; 59(2 Suppl 1):12-6. PubMed ID: 11832309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of benign prostatic hyperplasia.
    Edwards JL
    Am Fam Physician; 2008 May; 77(10):1403-10. PubMed ID: 18533373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia.
    DiSantostefano RL; Biddle AK; Lavelle JP
    BJU Int; 2006 May; 97(5):1007-16. PubMed ID: 16542339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging, newly-approved treatments for lower urinary tract symptoms secondary to benign prostatic hypertrophy.
    Pham H; Sharma P
    Can J Urol; 2018 Apr; 25(2):9228-9237. PubMed ID: 29679999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Benign hypertrophy of the prostate: which treatment, for whom?].
    Schulman C
    Rev Med Brux; 1999 Sep; 20(4):A212-8. PubMed ID: 10523895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign prostatic hyperplasia.
    Barry M; Roehrborn C; Webber R
    Clin Evid; 2002 Dec; (8):849-63. PubMed ID: 12603916
    [No Abstract]   [Full Text] [Related]  

  • 20. Transurethral bipolar plasmakinetic resection combined with 2 μm continuous wave laser vaporization: a new method for the treatment of large volume benign prostatic hyperplasia.
    Liao N; Yu J
    Photomed Laser Surg; 2012 Jun; 30(6):320-4. PubMed ID: 22472069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.